HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Therapeutics for Rare and Neglected Diseases

Work with TRND

The TRND program seeks to collaborate with academic, nonprofit, industry and other government researchers from within and outside the United States. By collaborating with TRND, partners with promising new therapeutic candidates benefit from the significant rare and neglected disease pre-clinical development expertise of TRND scientists. No funds are awarded through TRND. In general, the program leverages internal resources and pre-clinical and regulatory expertise to support the development of promising, well-validated therapeutic candidates from as early as lead compound optimization through submission of an Investigational New Drug application to the Food and Drug Administration.

TRND receives proposals for new collaborations through the online proposalCENTRAL system. Interested investigators undergo initial pre-screening to assess overall fit for the TRND program. Full proposals are rigorously assessed by TRND staff, with additional input from staff in other NIH Institutes and Centers and from external drug development experts. When a collaboration is initiated, TRND forms a project team and a project plan is developed, including a timeline, milestones, deliverables and “go/no-go” decision points.

Learn more about working with TRND:

Last updated: 03-21-2017
▲ Back to top